Schering-Plough Corporation today announced a license agreement between Nobilon, Schering-Plough's human vaccine business unit, and the World Health Organization (WHO) to provide access to pandemic influenza vaccine manufacturing technology to developing countries.
The details can be read here.
No comments:
Post a Comment